TRAZODONE HYDROCHLORIDE | A204852 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc. 1 patentANDA 204852trazodone hydrochloride | D. Del. | 2019-11-25 | Terminated 2021-09-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.5274
per ea
Lowest NADAC/Unit
$0.0325
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 13107008201TRAZODONE 300 MG TABLET | $0.5274 | EA | Generic | — | 2026-06-17 |
| 13107008105TRAZODONE 150 MG TABLET | $0.0900 | EA | Generic | — | 2026-06-17 |
| 13107008101TRAZODONE 150 MG TABLET | $0.0900 | EA | Generic | — | 2026-06-17 |
| 13107008005TRAZODONE 100 MG TABLET | $0.0495 | EA | Generic | — | 2026-06-17 |
| 13107008001TRAZODONE 100 MG TABLET | $0.0495 | EA | Generic | — | 2026-06-17 |
| 13107007901TRAZODONE 50 MG TABLET | $0.0325 | EA | Generic | — | 2026-06-17 |
| 13107007905TRAZODONE 50 MG TABLET | $0.0325 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.